Status:
WITHDRAWN
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment
Lead Sponsor:
EMS
Conditions:
VARICOSE VEINS
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate in the treatment of superficial varicose veins
Eligibility Criteria
Inclusion
- Patients must be able to understand the study procedures, agree to participate, and give written consent.
- Patients must be able to follow the study medication regimen.
- Patients with inflammatory process in superficial veins for more than 72 hours.
- Presence of symmetric lesions to compare one side to the other.
Exclusion
- Pregnancy or risk of pregnancy.
- Lactation.
- Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study
- Any alteration at other deep veins.
- History of atopy or allergic diseases.
- History of allergy to any component of the formulations.
- Other conditions considered by the investigator as reasonable for non-eligibility.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01203397
Start Date
September 1 2014
End Date
February 1 2015
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medcin Instituto Da Pele
Osasco, São Paulo, Brazil, 060323-000